Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking semaglutide experience some side effects, particularly in the early weeks — but the STEP 1 trial showed that the majority are gastrointestinal, predictable in timing, and manageable with the right habits. Clinical guidance from the NHS medicines page for semaglutide identifies practical steps that can meaningfully reduce how severe those side effects feel, without abandoning treatment that's working. These are prescription-only medicines, and any change to how you take them should be discussed with your prescriber rather than decided alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the STEP 1 trial, published in the New England Journal of Medicine, around 74% of participants on semaglutide 2.4mg reported gastrointestinal side effects, compared with roughly 48% on placebo. That sounds alarming until you look at the pattern: most events were mild to moderate, concentrated in the first few weeks after each dose increase, and the discontinuation rate due to side effects was around 7%. The design of the titration schedule (starting at 0.25mg and stepping up gradually over roughly five months) exists precisely to give the gut time to adapt before each increase. Side effects are not random bad luck; they follow a predictable curve tied to dose changes.
This matters for how you approach each new pen. The first week after stepping up is the highest-risk window for nausea and vomiting. Knowing that often helps, not because the symptoms feel better, but because you know they should ease. Our prescribers at nume often say that the patients who struggle most are the ones nobody warned properly at the start.
For a full breakdown of what the clinical record shows on individual side effects, the Wegovy side effects list covers the trial data in detail.
Semaglutide slows how quickly the stomach empties, that is part of how it reduces appetite, and it is also why large, rich meals become uncomfortable. Clinical guidance and the NHS semaglutide medicines page both point to the same practical adjustments: eat smaller portions at a slower pace, stop before you feel full, and avoid fatty or heavily spiced food in the early weeks of each new dose. Fizzy drinks add to bloating; plain water, sipped rather than gulped, helps with the nausea and keeps dehydration at bay if vomiting or diarrhoea occurs.
A question our prescribers hear most weeks is whether it matters when in the day you inject. The short answer is no, there is no clinical evidence that morning versus evening injections change side-effect rates. What does matter is consistency: injecting on the same day each week, with the pen at room temperature for a few minutes beforehand, and rotating injection sites between the abdomen, thigh and upper arm to avoid localised soreness.
Protein adequacy is worth mentioning too. Appetite suppression can mean eating far less than you realise; keeping protein intake reasonable (fish, eggs, legumes, dairy) helps protect lean muscle and tends to keep meals more satisfying, which reduces the temptation to overeat at a single sitting and trigger nausea. Personal targets should be discussed with a prescriber or dietitian.
For more on practical approaches once symptoms appear, see how to ease Wegovy side effects.
The vast majority of side effects on semaglutide are uncomfortable, not dangerous. But some symptoms require prompt medical review. The MHRA issued a Drug Safety Update in January 2026 identifying acute pancreatitis as a known, infrequent but serious risk across GLP-1 medicines: if you develop severe stomach pain that persists and radiates toward your back, with or without vomiting, stop treatment and seek urgent medical help. Do not wait to see whether it settles.
Gallbladder problems are another flagged concern, sudden pain in the upper right abdomen, especially with fever or jaundice, warrants urgent assessment. Severe or prolonged vomiting and diarrhoea can lead to dehydration quickly enough to affect kidney function; if you cannot keep fluids down for more than 24 hours, contact a doctor. Signs of an allergic reaction (rash, swelling of the face or throat, difficulty breathing) need emergency attention.
Low mood or thoughts of self-harm are listed in the safety information for semaglutide. If you notice any change in how you feel mentally, tell your prescriber.
For a fuller picture of which symptoms need action and which can be managed at home, treating Wegovy side effects covers the clinical guidance in detail. Any suspected serious side effect can also be reported to the MHRA via the Yellow Card scheme.
If side effects are severe or persistent, the right course is a conversation with your prescriber, not stopping abruptly on your own. Slowing the titration schedule, repeating a dose level for an extra month, or temporarily pausing treatment are all options a clinician can consider; the decision depends on the full picture of your health and how treatment is progressing. The guidance on stopping Wegovy side effects covers this in more detail, including what happens during and after treatment changes.
Wegovy is a prescription-only medicine, and the prescriber who approved treatment also needs to know when it is not going well. At nume, aftercare is available seven days a week, and our prescribers are there to review any concerns before a repeat order is issued. If you are considering Wegovy for the first time and want to understand what to expect, how long Wegovy side effects last gives an honest evidence-based timeline. For context on the broader treatment, the Wegovy overview is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.